What's better than a good thing? More of a good thing. Income investors can find plenty of "good things" in the market these ...
Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
PlanetDrugsDirect.com has been providing quality medications to satisfied American patients at heavily discounted prices for over twenty years.
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...
Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...
Investor's Business Daily on MSN5d
Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?Pfizer stock traded down Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.Please watch the video at Investors.com - How To Buy Stocks: ...
Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback